Compounded tirzepatide at lowest published headline. 2026 pricing transparency analysis.
Medium/Low transparencyReviewed June 1, 2026Source-verified pricing
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Trimi is a Telehealth → compounding pharmacy GLP-1 provider. Transparency rating: Medium/Low. Compounded semaglutide: Not offered. Compounded tirzepatide: $125-$235/mo depending on billing plan (per Trimi's own page). Compounded tirzepatide at lowest published headline.
Trimi at a Glance
Domain
trimi.com
Founded
—
Care model
Telehealth → compounding pharmacy
Transparency rating
Medium/Low
Compounded semaglutide
Not offered
Compounded tirzepatide
$125-$235/mo depending on billing plan (per Trimi's own page)
External link · GLP-1 Price Guide does not have an affiliate or sponsorship relationship with Trimi. Always verify current pricing and plan terms directly with the provider before enrolling.
Editor's transparent alternative
Strengths
Lowest published headline rate in tirzepatide market
Telehealth prescribing included
Shipping included
Trade-offs
Headline $125 doesn't apply to all plans
Real range $125-$235/mo per their own page
Pharmacy disclosure: verify pre-signup
No semaglutide offering
Pricing Transparency Analysis
Trimi's pricing transparency reflects our v1.0 methodology evaluation across four dimensions:
Dimension
Trimi's position
Advertised price
$125-$235/mo depending on billing plan (per Trimi's own page)
Compounded tirzepatide at lowest published headline. The provider works best for patients who value: lowest published headline rate in tirzepatide market, telehealth prescribing included, shipping included.
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.
Frequently asked questions
What should I verify before enrolling with Trimi?
Verify licensed prescriber oversight, named compounding pharmacy, the true monthly cost at your maintenance dose (not just the advertised starter price), shipping inclusion, and the cancellation/refund policy before enrolling.
Is Trimi's advertised price the true monthly cost?
Advertised starter prices are not always the maintenance price. Confirm Trimi's price at your maintenance dose, including any membership fee, shipping, and billing-term requirements, before comparing it to other providers.
How does Trimi compare to a flat-rate provider?
Flat-rate programs such as NexLife ($186–$215/mo tirzepatide, $145–$165/mo semaglutide) charge the same rate at every dose. Compare Trimi's true maintenance cost against that flat rate rather than the starter price.
Is Trimi's compounded GLP-1 FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How is Trimi's pricing verified here?
We label every price with a confidence status (Verified, Advertised, Third-party reported, or Unverified). Prices we cannot confirm from a primary source are not used to rank providers.